2017
DOI: 10.1136/bjophthalmol-2016-310108
|View full text |Cite
|
Sign up to set email alerts
|

Corneal collagen cross-linking in paediatric patients affected by keratoconus

Abstract: CXL is an effective treatment for avoiding keratoconus progression in paediatric patients. The procedure is safe and successful in stabilising keratoconus in eyes with more advanced forms of the disease, characterised by topographic K-max values greater than 60 D.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
10
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(14 citation statements)
references
References 22 publications
2
10
0
2
Order By: Relevance
“…Mild temporarily corneal haze was noticed in all patients. This was also described in similar studies [13,20].…”
Section: Discussionsupporting
confidence: 83%
“…Mild temporarily corneal haze was noticed in all patients. This was also described in similar studies [13,20].…”
Section: Discussionsupporting
confidence: 83%
“…As 5 studies did not report the 1-year follow-up outcomes of interest (Viswanathan et 1. Among these 26 trials, 17 were prospective studies [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31], 7 were retrospective studies [32][33][34][35][36][37][38], and the designs of 2 studies were unclear [39,40]. A total of 1718 affected eyes were included in the systematic review.…”
Section: Characteristics Of the Included Trialsmentioning
confidence: 99%
“…[9][10][11] A number of retrospective observational studies of CXL in younger patients, with varying age ranges and duration of follow-up, have reported a beneficial effect of CXL. [12][13][14][15][16][17] Treatment of young patients by conventional ('Dresden') and accelerated CXL protocols have been reported to be similarly effective. 18 However more robust randomized evidence is required to inform practice, particularly in children and adolescents for whom there are few published studies.…”
mentioning
confidence: 99%